 SPARTA, N.J., March 04, 2021 GLOBE NEWSWIRE -- PLx Pharma Inc. NASDAQ: PLXP PLx or the Company, a late-stage specialty pharmaceutical company focused on its clinically-validated and patent-protected PLxGuardTM drug delivery platform designed to provide more effective and safer products, announced today that the Company will release its 2020 fourth quarter financial results on Friday, March 12, 2021, before the U.S. financial markets open. 